In contrast, some markers were upregulated on CD56dim NK cells from NAFLD patients compared with HVs; among these, levels of CD57, PD-1, and ILT2 increased as fibrosis advanced (Figure 3B). Here, LILRB1 is linked to metabolic dysfunction-associated steatotic liver disease.